Advance care planning rose dramatically among minorities through intervention, study finds
By
Alicia Lasek
Feb 25, 2022
Older patients were more likely to record their end-of-life care wishes when they watched educational videos and received clinical counsel during the pandemic, a new study finds. Documentation among Black...
Docs miss — or opt to dismiss — signs of pulmonary embolism in dementia patients, study finds
By
Alicia Lasek
Sep 22, 2021
Physicians appear to place lower importance on factors that may lead to diagnosis of pulmonary embolism when evaluating patients with dementia who present with shortness of breath, investigators say.
Less popular hypertension drug has fewer side effects, study finds
By
Alicia Lasek
Jul 28, 2021
Two common choices for treating high blood pressure do a good job of preventing related cardiovascular events. But one drug class is less associated with swelling, cough, pancreas inflammation and gastrointestinal...
Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
Delirium present in 60 percent of residents’ acute illnesses, but tricky to diagnose: study
By
Alicia Lasek
Nov 15, 2021
Delirium may accompany 60% of the acute illnesses and adverse health events that occur commonly among residents, investigators say. Along with infections, regular use of benzodiazepines was linked to the...
CDC safety panel: J&J vaccine benefits outweigh rare neuro risks seen in older adults
By
Alicia Lasek
Jul 26, 2021
The benefits of the shot — including reduced hospitalization, intensive care unit admission and death — outweigh the risk of contracting Guillain-Barre syndrome, the Advisory Committee on Immunization...
AMDA aims for 25 percent meds reduction in data-sharing deprescribing campaign
By
Alicia Lasek
May 06, 2021
AMDA is challenging industry clinicians and operators to join a push to reduce polypharmacy. Prescribing data will be collected and overall trends analyzed and shared with participants.
Tooth survival after root canal varies widely across U.S. regions
By
Alicia Lasek (f3)
May 18, 2022
Tooth longevity ranges from about nine to 20 years after a root canal, depending in part on where one lives, a new study has found.
CDC: New SNF data show COVID-19 booster improves omicron protection
By
Alicia Lasek (f3)
May 06, 2022
Data from thousands of U.S. skilled nursing facilities show that a COVID-19 booster shot is more protective against omicron than an initial series alone, investigators say.
NSAIDs halt effect of osteoporosis drug, raising questions about fracture risk, analysts say
By
Alicia Lasek (f3)
Apr 21, 2022
Nonsteroidal anti-inflammatory drugs appear to negate the effect of at least one osteoporosis drug, according to an unexpected finding.